Desferrioxamine-related ocular toxicity: A case report.
Indian J Ophthalmol
;
2012 Jul-Aug; 60(4): 315-317
Article
in English
| IMSEAR
| ID: sea-144860
ABSTRACT
A 29-year-old lady receiving repeated blood transfusions for β thalassemia since childhood, presented with rapidly deteriorating symptoms of night blindness and peripheral visual field loss. She was recently commenced on high-dose intravenous desferrioxamine for reducing the systemic iron overload. Clinical and investigative findings were consistent with desferrioxamine-related pigmentary retinopathy and optic neuropathy. Recovery was partial following cessation of desferrioxamine. This report highlights the ocular side-effects of desferrioxamine mesylate and the need to be vigilant in patients on high doses of desferrioxamine.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Retinal Diseases
/
Blood Transfusion
/
Female
/
Humans
/
Beta-Thalassemia
/
Adult
/
Deferoxamine
Language:
English
Journal:
Indian J Ophthalmol
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS